RenovoRx is a medical device company developing novel catheter-based technologies for targeted delivery of fluids to the peripheral vessels. The company's proprietary, patented RenovoCath technology is designed to deliver chemotherapy directly to solid tumors.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/23/18 | $10,000,000 |
Acorn Campus Taiwan Astia Angels Boston Scientific  btov Partners Golden Seeds Halo Funds The Angels' Forum | undisclosed |
